Unspecified lentiviral vector gene therapy for beta-thalassemia
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Unspecified lentiviral vector gene therapy for beta-thalassemia, covering 2017-11-30 to 2017-11-30. Get the full timeline:
Most recent: Clinical Trial Update: Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector [NA]